KOLs working with Adaptive Biotechnologies
28 key opinion leaders with clinical trial sponsorships or reported industry payments from Adaptive Biotechnologies. Relationships are drawn from ClinicalTrials.gov sponsor records and CMS Open Payments, with every number cited to its source.
The 24 most cited
Paul Richardson, MD
Dana-Farber Cancer Institute
- 2,062
- publications
- 172
- h-index
- 17
- trials
Gareth Morgan, MD
NYU Langone Health
- 1,922
- publications
- 126
- h-index
- 4
- trials
Stephan Grupp, MD
Children's Hospital of Philadelphia
- 804
- publications
- 105
- h-index
- 13
- trials
William Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center
- 1,533
- publications
- 122
- h-index
- 19
- trials
Elias Jabbour, MD
The University of Texas MD Anderson Cancer Center
- 2,365
- publications
- 115
- h-index
- 38
- trials
Robert Orlowski, MD
The University of Texas MD Anderson Cancer Center
- 1,164
- publications
- 102
- h-index
- 10
- trials
Rafael Fonseca, MD
Mayo Clinic
- 894
- publications
- 121
- h-index
- 3
- trials
David Siegel, MD
John Theurer Cancer Center
- 699
- publications
- 83
- h-index
- 9
- trials
Daniel Deangelo, MD
Dana-Farber Cancer Institute
- 933
- publications
- 93
- h-index
- 10
- trials
Tapan Kadia, MD
The University of Texas MD Anderson Cancer Center
- 1,816
- publications
- 91
- h-index
- 30
- trials
Frederick Locke, MD
H. Lee Moffitt Cancer Center and Research Institute
- 863
- publications
- 62
- h-index
- 8
- trials
Richard Maziarz, MD
Oregon Health & Science University
- 720
- publications
- 86
- h-index
- 9
- trials
Parameswaran Hari, MD
Obsidian Therapeutics
- 917
- publications
- 79
- h-index
- 6
- trials
Paul Barr, MD
University of Rochester Medical Center
- 837
- publications
- 55
- h-index
- 32
- trials
Andrzej Jakubowiak, MD, PhD
University of Chicago
- 477
- publications
- 68
- h-index
- 11
- trials
Michael Verneris, MD
University of Colorado School of Medicine
- 497
- publications
- 67
- h-index
- 6
- trials
Ivan Borrello, MD
Tampa General Hospital Cancer Institute
- 282
- publications
- 60
- h-index
- 7
- trials
Matthew Davids, MD
Dana-Farber Cancer Institute
- 653
- publications
- 61
- h-index
- 9
- trials
Nicholas Short, MD
The University of Texas MD Anderson Cancer Center
- 1,096
- publications
- 66
- h-index
- 15
- trials
Luciano Costa, MD, PhD
University of Alabama at Birmingham
- 601
- publications
- 61
- h-index
- 5
- trials
Ajay Nooka, MD, MPH
Winship Cancer Institute of Emory University
- 691
- publications
- 55
- h-index
- 8
- trials
Ajai Chari, MD
University of California, San Francisco (UCSF)
- 487
- publications
- 51
- h-index
- 7
- trials
Yvonne Efebera, MD
OhioHealth
- 370
- publications
- 43
- h-index
- 6
- trials
Andrew Yee, MD
Massachusetts General Hospital Cancer Center
- 314
- publications
- 41
- h-index
- 11
- trials
Filter, sort, and export all 28 working with Adaptive Biotechnologies in the directory